Skip to main content
. Author manuscript; available in PMC: 2023 Mar 6.
Published in final edited form as: Am J Surg. 2022 May 31;224(4):1081–1085. doi: 10.1016/j.amjsurg.2022.05.036

Fig. 5.

Fig. 5.

Cross-sectional imaging of LS174T tumor (1 cm) 48 h after administration of 50 μg of MUC4-IR800. (a) Fluorescence imaging on LI-COR Odyssey of the transected tumor demonstrated the depth of penetration throughout the tumor. (b) Heat map imaging of fluorescence demonstrating the highest fluorescence signal at the periphery of the tumor with moderate signal throughout. (c) H&E imaging confirms the presence of colon cancer cells histologically (10x magnification).